Advagene Biopharma6709 
$0.631.23%24h
1.23%24h
Global rank25327
Market cap$33.45M
Change 7d7.89%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Advagene Biopharma (6709)
As of January 2025, Advagene Biopharma has a market cap of $33.45M. This makes Advagene Biopharma the world's 25327th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Advagene Biopharma from 2018 to 2024
-
Value:-
Market cap history of Advagene Biopharma from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $38.18M | -10.69% |
| 2023 | $42.75M | -12.81% |
| 2022 | $49.03M | -37.46% |
| 2021 | $78.39M | 45.39% |
| 2020 | $53.92M | 65.25% |
| 2019 | $32.63M | -23.08% |
| 2018 | $42.42M | - |
6709 Market Cap Today is $33.45M 1.23% - 29 Jan 2025
View largest stocks by market cap 
